MND-2119

· Mochida Pharmaceutical Company, Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MND-2119, covering 2019-08-01 to 2021-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia [Phase 3]